Skip to content

Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy

Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05367869
Acronym
methylene
Enrollment
40
Registered
2022-05-10
Start date
2022-06-01
Completion date
2023-05-31
Last updated
2022-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy

Keywords

methylene blue, spraying, intraoperative, thyroidectomy

Brief summary

Impact of Intraoperative Spraying methylene blue In thyroidectomy

Detailed description

General anaesthesia ,supine position with hyperextension to the neck Low collar incision to the neck , incision to the skin and platysma muscle and fascia ,upper and lower flaps are developed ,separation of strap muscles and identification of the thyroid gland after freeing of investing fascia Ligation of the middle thyroid vein and ligation and separation of the superior pedicle away from the external laryngeal nerve At this point of operation and before ligation of inferior pedicle, methylene blue 0.05% spraying is applied to the field the amount varies according to size of the thyroid lobe and variation in population and neck size Thyroid gland stained by bluish color , recurrent laryngeal nerve not stained or minimally stained so we can avoid injury to it parathyroid glands get red of the stain after about 3 minutes so we can avoid injury to it thyroid gland lose its stain in about 15 minutes so we can remove any residual and decrease residual tissue or recurrence

Interventions

PROCEDUREImpact of Intraoperative Spraying Methylene Blue In Thyroidectomy

General anaesthesia ,supine position with hyperextension to the neck Low collar incision to the neck , incision to the skin and platysma muscle and fascia ,upper and lower flaps are developed ,separation of strap muscles and identification of the thyroid gland after freeing of investing fascia Ligation of the middle thyroid vein and ligation and separation of the superior pedicle away from the external laryngeal nerve At this point of operation and before ligation of inferior pedicle methylene blue 0.05% spraying is applied to the field the amount varies according to size of the thyroid lobe and variation in population and neck size Thyroid gland stained by bluish color , recurrent laryngeal nerve not stained or minimally stained so we can avoid injury to it parathyroid glands get red of the stain after about 3 minutes so we can avoid injury to it thyroid gland lose its stain in about 15 minutes so we can remove any residual and decrease residual tissue or recurrence

Sponsors

Qena Oncology Center
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy

Eligibility

Sex/Gender
ALL
Age
15 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Both sexes * Age more than 15 years * All pathologies need surgery eg. (mutinodular goiter, malignancy , thyroid nodule,…..etc * Total thyroidectomy

Exclusion criteria

* Pregnant females * Previous neck surgery or recurrent thyroid surgery * Subtotal or partial thyroidectomy * Age less than 15 years * Preoperative affection to vocal cord * Preoperative hypocalcaemia

Design outcomes

Primary

MeasureTime frame
Operative time1 day
Presence of residual or recurrence3 months
Recurrent laryngeal nerve injury2 weeks
Parathyroid gland Injuries3 months
Intraoperative injury to trachea2 weeks

Secondary

MeasureTime frameDescription
Stridor3 monthstemporary or permanent (by clinical evaluation and vocal cord examination)
Hypoparathyroidism3 monthstemporary or permanent (level of para thormone hormone )
Hypocalcaemia3 monthstemporary or permanent ( level of total and free serum calcium )
Hoarseness of voice3 monthstemporary or permanent (by clinical evaluation and vocal cord examination)

Contacts

Primary ContactMohamed Ahmed Orabi, Specialist Surgical Oncology
Mohamedorabi5885@gmail.com+2 01001868637
Backup ContactAmr M Makky, Specialist Surgical Oncology
Amr.mostafa.makky@gmail.com+2 010222339139

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026